FULC

Bearish

Levi & Korsinsky Announces Investigation of Securities Claims Against Fulcrum Therapeutics, Inc. (FULC)

Levi & Korsinsky, LLP has announced an investigation into potential securities claims against Fulcrum Therapeutics, Inc. (NASDAQ: FULC) following a si...

GlobeNewswire 2 weeks ago 0

Bearish

This Biotech Stock Plunges 48%. Its Sickle Cell Drug Has ‘No Viable Path Forward.’

Fulcrum Therapeutics' stock plummeted by 48% after the company announced it would discontinue pociredir, its lead drug candidate for sickle cell disea...

Barron's 2 weeks ago 0